Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06573177

Optimizing Individual Health Care for Young People With Gender Incongruence

This observational study focuses on evaluating the effect of the current health care program for Danish children and adolescents with gender incongruence, which was established in January 2016. Somatic outcome parameters include growth, bone health, body composition, metabolic parameters, hormone levels and concurrent diseases. Psychosocial parameters include the trajectory of gender incongruence development, mental health, i.e. autism spectrum disorders, behavioural problems, self-harm, suicidal ideation and psychiatric diagnoses, and social context, i.e. family demographics, education, minority stress.

This study aims to:

1. Characterise the psychosocial profile of all children and adolescents referred for treatment, as well as the history of gender identity development and treatment trajectories. 2. Systematically evaluate biological parameters before and during hormonal treatment with gonadotropin-releasing hormone (GnRH) analogues and cross-sex hormones, and to establish a biobank for those in hormone treatment.

The investigators hypothesise that intervention with counselling and hormonal treatment is safe and has a positive impact on psychosocial well-being of transgender youngsters. The overall aim is to provide data for improving future family counselling, clinical care, patient satisfaction, patient safety and ultimately quality-of-life.

Recruiting

Interested in participating?

Request Info

Key information

Age range

Up to 18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Growth and Reproduction, Rigshospitalet

Copenhagen, Capital Region, 2100, Denmark

Location status: Recruiting

Location contact

Katharina M Main

CONTACT

[email protected]

+4535455085

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Accepted referral to the gender identity service.

Exclusion criteria

  • None.

Treatment and study plan

Referral to the gender identity service.

Other

Referral to the national gender identity service consisting of the Sexological Clinic, Child and Adolescent Mental Health Center, and Department of Growth and Reproduction in the Capital Region of Denmark.

Primary outcomes

  1. Body Mass Index (BMI)

    Time frame: 8 years

    BMI will be calculated from height and weight (kg/m^2) measurements

  2. Puberty

    Time frame: 8 years

    Tanner stages of puberty (1-5) are obtained by clinical examination

  3. Bone mineral content (BMD)

    Time frame: 8 years

    Whole body dual-energy x-ray absorptiometry (DXA) will determine BMD Z-score for age and sex

  4. Body fat

    Time frame: 8 years

    Whole body dual-energy x-ray absorptiometry (DXA) will measure body fat percentage (%)

  5. Lean body mass

    Time frame: 8 years

    Whole body dual-energy x-ray absorptiometry (DXA) will measure lean mass (kg)

  6. Reproductive serum hormone levels

    Time frame: 8 years

    Changes in reproductive hormone levels (%)

  7. Adrenal serum hormone levels

    Time frame: 8 years

    Changes in adrenal hormone levels (%)

  8. Blood pressure

    Time frame: 8 years

    Changes in blood pressure measurement (mm Hg)

  9. Transabdominal ultrasound of uterus

    Time frame: 8 years

    Changes of endometrium (thickness in mm) during testosterone treatment

  10. Transabdominal ultrasound of ovaries

    Time frame: 8 years

    Change in number of follicles (n) during testosterone treatment

  11. Sperm count

    Time frame: 8 years

    Sperm Count (at cryopreservation)

  12. Sperm motility

    Time frame: 8 years

    Sperm motility (at cryopreservation)

  13. Morbidity

    Time frame: 8 years

    Number of participants with registered ICD10 diagnoses

  14. Demographic characteristics

    Time frame: 8 years

    eg. socioeconomic status

  15. Prevalence of psychiatric disorders

    Time frame: 8 years

    Based on screening for psychopathology using validated tests, as indicated:

    Schedule for Affective Disorders and Schizophrenia for School-age children (K-SADS):

    A diagnostic tool used to assess psychiatric disorders in children and adolescents. It is a semi-structured interview guide used to identify psychiatric conditions.

    Wechsler Intelligence Scale for Children (WISC 4/5) or Wechsler Adult Intelligence Scale (WAIS 4): General cognitive function is measured on a scale from 40-160 which is used as an intelligence quotient. A higher score: A higher cognitive function.

    Rorschach: A projective psychological test. The test uses a series of ink blots to evaluate a person's mental functions and emotional state by analysing their perceptions of the figures. The test is based on complex and subjective scoring and interpretation.

  16. Prevalence of Attention Deficit Hyperactive Disorder (ADHD)

    Time frame: 8 years

    Screening using validated tests:

    Behavior Rating Inventory of Executive Function (BRIEF): General executive function is measured on a normative scale with T-scores from 20-80. A higher score: more executive difficulties.

    Attention Deficit/Hyperactive Disorder-Rating Scale (ADHD-RS): Attention Deficit Hyperactive Disorder traits measured on a normative scale with T-scores from 0-78. A higher score: More Attention Deficit Hyperactive Disorder traits

  17. Prevalence of autism spectrum disorder

    Time frame: 8 years

    Screening using validated tests:

    Social Responsiveness Scale (SRS): Autism spectrum disorder (ASD) traits measured on a scale with T-scores from 0-76+. A higher score: More autistic traits.

    Autism Diagnostic Observation Schedule (ADOS): A structured observational tool to assess ASD. A trait is rated on a scale from 0 to 3. 0 indicates absence of a behaviour and 3 indicates severe occurrence of a behaviour. The total score determines the presence and severity of ASD. The cut-off scores are 10 for autism and 7 for ASD traits.

    Autism Diagnostic Interview-Revised (ADI-R): A structured interview used to assess ASD traits. Interview questions are scored on a scale from 0-3. 0 indicates absence of a behaviour and 3 indicates severe occurrence of a behaviour. The scores compared with cut-off values determine the presence of ASD. Cut-off values for each trait: Social interaction: cut-off 10; Communication skills: cut-off 8; Restrictive and repetitive behaviour patterns: cut-off 3.

  18. Global level of functioning

    Time frame: 8 years

    Children's Global Assessment Scale (C-GAS, range 1-100)

  19. Psychosocial Disability

    Time frame: 8 years

    Global Assessment of Psychosocial Disability (GAPD, range 0-8)

  20. Suicide risk

    Time frame: 8 years

    Number of participants with self-reported suicide thoughts or attempts (interview)

  21. Substance abuse.

    Time frame: 8 years

    Number participants with self-reported abuse of alcohol, drugs or medications (interview)

  22. Personal history of gender incongruence (GI)

    Time frame: 8 years

    Age at onset of GI and social transitioning (interview)

  23. Cultural measures

    Time frame: 8 years

    Interviews with youngsters and their families to explore:

    • The experiences that are influential in the process of seeking gender-affirming treatment. 2) Treatment expectations and wishes. 3) The cultural understandings of gender, sex, body and identity that inform the decision to seek treatment. 4) The role of the family in the decision to seek treatment.
  24. Establishment of biobank

    Time frame: 8 years.

    Serum, plasma, DNA at -20 and -80 degrees Celsius.

Study contacts

Contact information is provided by the study sponsor or research team.

Annamaria GE Giraldi

CONTACT

[email protected]

Katharina M Main

CONTACT

[email protected]

+4535455085

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Official study title

Gender Incongruence in Danish Youth (GenDa): An Observational Cohort Study of Danish Children and Adolescents Referred to a National Gender Identity Service

Important dates

Study start
2022
Primary completion
2025
Study completion
2030
First posted
Aug 27, 2024
Registry last updated
Aug 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.